查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1701870

2025 年至 2033 年重組蛋白市場報告（按產品、應用、最終用戶和地區）

Recombinant Protein Market Report by Product, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球重組蛋白市場規模達 21 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 50 億美元，2025-2033 年期間的成長率 (CAGR) 為 9.55%。

重組蛋白是指由重組DNA編碼的經過修飾或改變的蛋白質。重組 DNA 分子由質粒組成，其中克隆了目標蛋白質的基因。它是透過分子克隆或聚合酶鍊式反應（PCR）產生的。一些常見的產品變體包括激酶蛋白、人類胰島素、結構蛋白、黏附分子和受體、免疫反應蛋白等。重組蛋白主要用於開發慢性和罕見疾病的新療法。它在眾多生物製藥公司、學術和研究機構、合約研究組織等中得到廣泛應用。

重組蛋白市場趨勢：

多種慢性疾病的盛行率不斷上升以及對新型治療方案的需求不斷增加是推動全球重組蛋白市場發展的主要因素。除此之外，蛋白質工程領域的投資不斷增加以及對蛋白質藥物開發的關注度不斷提高，進一步促進了市場的成長。此外，許多政府機構正在資助引進蛋白質體學和基因組學先進技術的研發活動，這對全球重組蛋白市場產生了重大影響。除此之外，重組蛋白表現技術的出現促進了在免疫治療程序中廣泛使用的高品質自體抗原的開發。此外，藥物研發領域對重組蛋白進行精確測量的需求不斷成長，也為全球市場創造了積極的前景。除此之外，最新分子生物學方法在生物製藥中的滲透率不斷提高，以減少重組蛋白的蛋白水解或防止糖基化的部分或全部損失，預計將在預測期內提振全球重組蛋白市場。

本報告回答的關鍵問題

  • 2024 年全球重組蛋白市場規模？ 2025-2033年全球重組蛋白市場的預期成長率是多少？
  • 推動全球重組蛋白市場發展的關鍵因素有哪些？
  • COVID-19 對全球重組蛋白市場有何影響？
  • 根據應用，全球重組蛋白市場是如何分佈的？
  • 根據最終用戶，全球重組蛋白市場的分佈如何？
  • 全球重組蛋白市場的主要區域有哪些？
  • 全球重組蛋白市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球重組蛋白市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 抗體
  • 荷爾蒙
  • 生長因子
  • 細胞因子
  • 其他

第7章：市場區隔：依應用

  • 藥物研發
  • 學術研究
  • 生物技術研究
  • 生物製藥生產
  • 其他

第8章：市場區隔：按最終用戶

  • 製藥和生物製藥公司
  • 生技公司
  • 學術和研究機構
  • 合約研究組織
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abcam plc
    • Amgen Inc.
    • Bio-RAD Laboratories Inc.
    • Bio-Techne Corporation
    • Bps Bioscience Inc.
    • Enzo Biochem Inc.
    • Genscript Biotech Corporation
    • Merck KGaA
    • Novo Nordisk A/S
    • ProSpec-Tany TechnoGene Ltd
    • Sanofi SA
    • Thermo Fisher Scientific
Product Code: SR112025A6079

The global recombinant protein market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.55% during 2025-2033.

A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.

Recombinant Protein Market Trends:

The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth. Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures. Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecast period.

Key Market Segmentation:

Breakup by Product:

  • Antibodies
  • Hormones
  • Growth Factors
  • Cytokines
  • Others

Breakup by Application:

  • Drug Discovery and Development
  • Academic Research
  • Biotechnology Research
  • Biopharmaceutical Production
  • Others

Breakup by End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organization
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.

Key Questions Answered in This Report

  • 1.What was the size of the global recombinant protein market in 2024?
  • 2.What is the expected growth rate of the global recombinant protein market during 2025-2033?
  • 3.What are the key factors driving the global recombinant protein market?
  • 4.What has been the impact of COVID-19 on the global recombinant protein market?
  • 5.What is the breakup of the global recombinant protein market based on application?
  • 6.What is the breakup of the global recombinant protein market based on the end user?
  • 7.What are the key regions in the global recombinant protein market?
  • 8.Who are the key players/companies in the global recombinant protein market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Recombinant Protein Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hormones
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Growth Factors
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cytokines
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Academic Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biotechnology Research
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Biopharmaceutical Production
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Biopharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Contract Research Organization
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Techne Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bps Bioscience Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Enzo Biochem Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Genscript Biotech Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novo Nordisk A/S
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 ProSpec-Tany TechnoGene Ltd
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Recombinant Protein Market: Major Drivers and Challenges
  • Figure 2: Global: Recombinant Protein Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Recombinant Protein Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Recombinant Protein Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Recombinant Protein Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Recombinant Protein Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Recombinant Protein Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Recombinant Protein (Antibodies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Recombinant Protein (Antibodies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Recombinant Protein (Hormones) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Recombinant Protein (Hormones) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Recombinant Protein (Growth Factors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Recombinant Protein (Growth Factors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Recombinant Protein (Cytokines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Recombinant Protein (Cytokines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Recombinant Protein (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Recombinant Protein (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Recombinant Protein (Drug Discovery and Development) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Recombinant Protein (Drug Discovery and Development) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Recombinant Protein (Academic Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Recombinant Protein (Academic Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Recombinant Protein (Biotechnology Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Recombinant Protein (Biotechnology Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Recombinant Protein (Biopharmaceutical Production) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Recombinant Protein (Biopharmaceutical Production) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Recombinant Protein (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Recombinant Protein (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Recombinant Protein (Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Recombinant Protein (Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Recombinant Protein (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Recombinant Protein (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Recombinant Protein (Contract Research Organization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Recombinant Protein (Contract Research Organization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Recombinant Protein (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Recombinant Protein (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Recombinant Protein Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Recombinant Protein Industry: SWOT Analysis
  • Figure 88: Global: Recombinant Protein Industry: Value Chain Analysis
  • Figure 89: Global: Recombinant Protein Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Recombinant Protein Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Recombinant Protein Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Recombinant Protein Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Recombinant Protein Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Recombinant Protein Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Recombinant Protein Market: Competitive Structure
  • Table 7: Global: Recombinant Protein Market: Key Players